
Guidelines to Diagnosis and Monitoring of Fabry Disease and Review of Treatment Experiences
Keywords: پلیمورفیسم تکاملی تک رشته; α-Gal A; α-Galactosidase A; CKD; Chronic kidney disease; eGFR; Estimated glomerular filtration rate; ERT; Enzyme replacement therapy; GLA; α-Galactosidase A gene; GL-3; Globotriaosylceramide; GL-2; Lactosylceramide; HDL; High-density lipoprotein; LDL;